These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The detection of gram-negative bacteria in the blood of septic rats by a Limulus amebocyte lysate assay. du Moulin GC; Lynch SE; Hedley-Whyte J; Broitman SA Prog Clin Biol Res; 1987; 231():349-56. PubMed ID: 3588630 [No Abstract] [Full Text] [Related]
25. Mannose-binding lectin is a critical factor in systemic complement activation during meningococcal septic shock. Sprong T; Mollnes TE; Neeleman C; Swinkels D; Netea MG; van der Meer JW; van Deuren M Clin Infect Dis; 2009 Nov; 49(9):1380-6. PubMed ID: 19793001 [TBL] [Abstract][Full Text] [Related]
26. Clinical evaluation of the plasma chromogenic Limulus assay. Dolan SA; Riegle L; Berzofsky R; Cooperstock M Prog Clin Biol Res; 1987; 231():405-16. PubMed ID: 3588633 [TBL] [Abstract][Full Text] [Related]
27. Plasma interferon-gamma and interleukin-10 concentrations in systemic meningococcal disease compared with severe systemic Gram-positive septic shock. Bjerre A; Brusletto B; Høiby EA; Kierulf P; Brandtzaeg P Crit Care Med; 2004 Feb; 32(2):433-8. PubMed ID: 14758160 [TBL] [Abstract][Full Text] [Related]
28. Septic shock; current pathogenetic concepts from a clinical perspective. Tsiotou AG; Sakorafas GH; Anagnostopoulos G; Bramis J Med Sci Monit; 2005 Mar; 11(3):RA76-85. PubMed ID: 15735579 [TBL] [Abstract][Full Text] [Related]
29. Therapies for sepsis. Emerging therapies for sepsis and septic shock. Abraham E West J Med; 1997 Mar; 166(3):195-200. PubMed ID: 9143195 [No Abstract] [Full Text] [Related]
31. Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapy. Hack CE; Ogilvie AC; Eisele B; Jansen PM; Wagstaff J; Thijs LG Prog Clin Biol Res; 1994; 388():335-57. PubMed ID: 7831367 [TBL] [Abstract][Full Text] [Related]
32. Pathophysiology of endotoxin shock in primates and the effect of various therapeutic agents. Vaughn DL; Peterson E Obstet Gynecol; 1969 Aug; 34(2):271-6. PubMed ID: 4978957 [No Abstract] [Full Text] [Related]
37. Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock. Jansen PM; Eisele B; de Jong IW; Chang A; Delvos U; Taylor FB; Hack CE J Immunol; 1998 Jan; 160(1):475-84. PubMed ID: 9552006 [TBL] [Abstract][Full Text] [Related]
38. Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock. Humes HD; Buffington DA; Lou L; Abrishami S; Wang M; Xia J; Fissell WH Crit Care Med; 2003 Oct; 31(10):2421-8. PubMed ID: 14530746 [TBL] [Abstract][Full Text] [Related]
39. [Management in endotoxin shock]. Stengert K; Brodzińska K Pol Tyg Lek; 1966 Oct; 21(42):1602-4. PubMed ID: 5925572 [No Abstract] [Full Text] [Related]
40. Management of shock. Singhi S Indian Pediatr; 1999 Mar; 36(3):265-88. PubMed ID: 10713840 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]